1ZU Stock Overview
The Pennant Group, Inc. provides healthcare services in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
The Pennant Group, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$20.80 |
| 52 Week High | US$20.80 |
| 52 Week Low | US$9.80 |
| Beta | 2.01 |
| 1 Month Change | 9.47% |
| 3 Month Change | 44.44% |
| 1 Year Change | 101.94% |
| 3 Year Change | -24.09% |
| 5 Year Change | n/a |
| Change since IPO | 30.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1ZU | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 4.0% | 2.2% | 2.5% |
| 1Y | 101.9% | -1.1% | 6.0% |
Return vs Industry: 1ZU exceeded the German Healthcare industry which returned -4.1% over the past year.
Return vs Market: 1ZU exceeded the German Market which returned 5.4% over the past year.
Price Volatility
| 1ZU volatility | |
|---|---|
| 1ZU Average Weekly Movement | 6.0% |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1ZU's share price has been volatile over the past 3 months.
Volatility Over Time: 1ZU's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 5,791 | Brent Guerisoli | www.pennantgroup.com |
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
The Pennant Group, Inc. Fundamentals Summary
| 1ZU fundamental statistics | |
|---|---|
| Market cap | €620.24m |
| Earnings (TTM) | €15.25m |
| Revenue (TTM) | €534.03m |
41.4x
P/E Ratio1.2x
P/S RatioIs 1ZU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1ZU income statement (TTM) | |
|---|---|
| Revenue | US$575.34m |
| Cost of Revenue | US$453.82m |
| Gross Profit | US$121.52m |
| Other Expenses | US$105.09m |
| Earnings | US$16.44m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.55 |
| Gross Margin | 21.12% |
| Net Profit Margin | 2.86% |
| Debt/Equity Ratio | 50.7% |
How did 1ZU perform over the long term?
See historical performance and comparison